A multistep kinase-based Sertoli cell autocrine-amplifying loop regulates prostaglandins, their receptors, and cytokines

Endocrinology

Volumn 147, Issue 4, 2006, Pages 1706-1716

  Ishikawa, Tomomoto ^a   Morris, Patricia L ^a,b  

^a POPULATION COUNCIL   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11 DEOXYPROSTAGLANDIN E1; BUTAPROST; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOOXYGENASE 2; CYTOKINE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN RECEPTOR; PROSTANOID RECEPTOR; PROTEIN KINASE C; RECEPTOR SUBTYPE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; FEEDBACK SYSTEM; HORMONE SYNTHESIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SEMINIFEROUS TUBULE; SERTOLI CELL; SIGNAL TRANSDUCTION;

ANIMALS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLOOXYGENASE 2; CYTOKINES; INTERLEUKIN-1; MALE; PROSTAGLANDINS; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROSTAGLANDIN; RNA, MESSENGER; SERTOLI CELLS;

EID: 33645498529     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-1576     Document Type: Article

References (40)

1. Kirschenbaum A, Liotta DR, Yao S, Liu XH, Klausner AP, Unger P, Shapiro E, Leav I, Levine AC 2000 Immunohistochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the human fetal and adult male reproductive tracts. J Clin Endocrinol Metab 85:3436-3441
2. Breyer MD, Hebert RL, Breyer RM 2003 Prostanoid receptors and the urogenital tract. Curr Opin Investig Drugs 4:1343-1353
3. Challis JR 1997 Prostaglandins and reproduction - what do knockouts really tell us? Nat Med 3:1326-1327
4. 2. Proc Natl Acad Sci USA 96:10501-10506
5. Sales KJ, Jabbour HN 2003 Cyclooxygenase enzymes and prostaglandins in reproductive tract physiology and pathology. Prostaglandins Other Lipid Mediat 71:97-117
6. 2 receptor. Nat Med 5:217-220
7. 2α. Mol Cell Endocrinol 138:143-150
8. Lazarus M, Munday CJ, Eguchi N, Matsumoto S, Killian GJ, Kubata BK, Urade Y 2002 Immunohistochemical localization of microsomal PGE synthase-1 and cyclooxygenases in male mouse reproductive organs. Endocrinology 143:2410-2419
9. Walch L, Morris PL 2002 Cyclooxygenase 2 pathway mediates IL-1β regulation of IL-1α, -1β, and IL-6 mRNA levels in Leydig cell progenitors. Endocrinology 143:3276-3283
10. 1 receptor subtype selectivity takes shape. Mol Pharmacol 59:1357-1359
11. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD 2001 Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 41:661-690
12. 2 regulation of interleukin-1β expression in Leydig cell progenitors. Endocrinology 144:1284-1291
13. Abramovitz M, Boie Y, Nguyen T, Rushmore TH, Bayne MA, Metters KM, Slipetz DM, Grygorczyk R 1994 Cloning and expression of a cDNA for the human prostanoid FP receptor. J Biol Chem 269:2632-2636
14. Coleman RA, Smith WL, Narumiya S 1994 International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46:205-229
15. Smith WL, DeWitt DL, Garavito RM 2000 Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69:145-182
16. Hales DB 1992 Interleukin-1 inhibits Leydig cell steroidogenesis primarily by decreasing 17α-hydroxylase/C17-20 lyase cytochrome P450 expression. Endocrinology 131:2165-2172
17. Xiong Y, Hales DB 1997 Differential effects of tumor necrosis factor-α and interleukin-1 on 3β-hydroxysteroid dehydrogenase/ δ5→δ4 isomerase expression in mouse Leydig cells. Endocrine 7:295-301
18. Calkins JH, Sigel MM, Nankin HR, Lin T 1988 Interleukin-1 inhibits Leydig cell steroidogenesis in primary culture. Endocrinology 123:1605-1610
19. Wang D, Nagpal ML, Shimasaki S, Ling N, Lin T 1995 Interleukin-1 induces insulin-like growth factor binding protein-3 gene expression and protein production by Leydig cells. Endocrinology 136:4049-4055
20. Lin T, Wang D, Stocco DM 1998 Interleukin-1 inhibits Leydig cell steroidogenesis without affecting steroidogenic acute regulatory protein messenger ribonucleic acid or protein levels. J Endocrinol 156:461-467
21. Okuda Y, Bardin CW, Hodgskin LR, Morris PL 1995 Interleukins-1α and -1β regulate interleukin-6 expression in Leydig and Sertoli cells. Recent Prog Horm Res 50:367-372
22. Okuda Y, Sun X-R, Morris PL 1994 Interleukin-6 (IL-6) mRNAs expressed in Leydig and Sertoli cells are regulated by cytokines, gonadotropins and neuropeptides. Endocrine 2:617-624
23. Ishikawa T, Hwang K, Lazzarino D, Morris PL 2005 Sertoli cell expression of steroidogenic acute regulatory protein-related lipid transfer 1 and 5 domain-containing proteins and sterol regulatory element binding protein-1 are interleukin-1β regulated by activation of c-jun N-terminal kinase and cyclooxygenase-2 and cytokine induction. Endocrinology 146:5100-5111
24. Morris PL, Vale WW, Cappel S, Bardin CW 1988 Inhibin production by primary Sertoli cell-enriched cultures: regulation by follicle-stimulating hormone, androgens, and epidermal growth factor. Endocrinology 122:717-725
25. Kanzaki M, Morris PL 1998 Identification and regulation of testicular interferon γ (IFN-γ) receptor subunits: IFN-γ enhances interferon regulatory factor-1 (IRF-1) and interleukin-1β converting enzyme (ICE) expression. Endocrinology 139:2636-2644
26. Cudicini C, Kercret H, Touzalin AM, Ballet F, Jegou B 1997 Vectorial production of interleukin 1 and interleukin 6 by rat Sertoli cells cultured in a dual culture compartment system. Endocrinology 138:2863-2870
27. Abramovitz M, Adam M, Boie Y, Carriere M, Denis D, Godbout C, Lamontagne S, Rochette C, Sawyer N, Tremblay NM, Belley M, Gallant M, Dufresne C, Gareau Y, Ruel R, Juteau H, Labelle M, Ouimet N, Metters KM 2000 The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta 1483:285-293
28. 1) receptor agonist-induced DNA synthesis and proliferation in primary cultures of adult rat hepatocytes: the involvement of TGF-α. Endocrinology 142:4428-4440
29. Narumiya S, FitzGerald GA 2001 Genetic and pharmacological analysis of prostanoid receptor function. J Clin Invest 108:25-30
30. Fujino H, Srinivasan D, Pierce KL, Regan JW 2000 Differential regulation of prostaglandin F2α receptor isoforms by protein kinase C. Mol Pharmacol 57:353-358
31. Negishi M, Sugimoto Y, Ichikawa A 1995 Molecular mechanisms of diverse actions of prostanoid receptors. Biochim Biophys Acta 1259:109-119
32. Walker WH, Fucci L, Habener JF 1995 Expression of the gene encoding transcription factor cyclic adenosine 3′,5′ -monophosphate (cAMP) response element-binding protein (CREB): regulation by follicle-stimulating hormone-induced cAMP signaling in primary rat Sertoli cells. Endocrinology 136:3534-3545
33. Don J, Stelzer G 2002 The expanding family of CREB/CREM transcription factors that are involved with spermatogenesis. Mol Cell Endocrinol 187:115-124
34. Dinarello CA 1997 Interleukin-1. Cytokine Growth Factor Rev 8:253-265
35. Okuda Y, Morris PL 1994 Identification of interleukin-6 receptor (IL-6R) mRNA in isolated Sertoli and Leydig cells: regulation by gonadotropin and interleukins in vitro. Endocrine 2:1163-1168
36. 2α receptor-dependent regulation of prostaglandin transport. Mol Pharmacol 59:1506-1513
37. 2. Distinct roles of cyclooxygenase-1 and -2. J Biol Chem 272:25693-25699
38. Gerard N, Syed V, Jegou B 1992 Lipopolysaccharide, latex beads and residual bodies are potent activators of Sertoli cell interleukin-1α production. Biochem Biophys Res Commun 185:154-161
39. Syed V, Gerard N, Kaipia A, Bardin CW, Parvinen M, Jegou B 1993 Identification, ontogeny, and regulation of an interleukin-6-like factor in the rat seminiferous tubule. Endocrinology 132:293-299
40. Syed V, Stephan J-P, Gerard N, Legrand A, Parvinen M, Bardin CW, Jegou B 1995 Residual bodies activate Sertoli cell interleukin-1α (IL-1α) release, which triggers IL-6 production by an autocrine mechanism, through the lipoxygenase pathway. Endocrinology 136:3070-3078